A Novel Formulation of Epoprostenol with Antimicrobial Properties, Administered Under Ambient Conditions, for Treatment of Patients with Pulmonary Arterial Hypertension

被引：0
|
作者：
Witchey-Lakshmanan, L.
Palepu, N.
Teja, B. B.
机构：
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2010年 / 181卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A3364
引用
收藏
页数：1
相关论文
共 50 条
  • [1] A new epoprostenol formulation for the treatment of pulmonary arterial hypertension
    Fuentes, Amaris
    Coralic, Aida
    Dawson, Kyle L.
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (16) : 1389 - 1393
  • [2] Epoprostenol for the treatment of pulmonary arterial hypertension
    Cristo Ropero, Maria Jose
    Cruz-Utrilla, Alejandro
    Pilar Escribano-Subias, Maria
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2021, 14 (08) : 1005 - 1013
  • [3] Stability and preservation of a new formulation of epoprostenol sodium for treatment of pulmonary arterial hypertension
    Lambert, Olivier
    Bandilla, Dirk
    DRUG DESIGN DEVELOPMENT AND THERAPY, 2012, 6 : 235 - 244
  • [4] Epoprostenol sodium for treatment of pulmonary arterial hypertension
    Saito, Yukihiro
    Nakamura, Kazufumi
    Akagi, Satoshi
    Sarashina, Toshihiro
    Ejiri, Kentaro
    Miura, Aya
    Ogawa, Aiko
    Matsubara, Hiromi
    Ito, Hiroshi
    VASCULAR HEALTH AND RISK MANAGEMENT, 2015, 11 : 265 - 270
  • [5] Use of Epoprostenol in the Treatment of Pulmonary Arterial Hypertension
    Mohammadi, Asma
    Matos, Wanessa F.
    Intriago, Cesar
    Thakkar, Keval
    Jahan, Nasrin
    Shah, Heeya
    Nishu, Rifath I.
    Marzban, Sima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (09)
  • [6] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
    M J Garabedian
    W F Hansen
    E A Gianferrari
    K Y Lain
    R Y Fragneto
    C L Campbell
    D C Booth
    Journal of Perinatology, 2010, 30 : 628 - 631
  • [7] Epoprostenol treatment for idiopathic pulmonary arterial hypertension in pregnancy
    Garabedian, M. J.
    Hansen, W. F.
    Gianferrari, E. A.
    Lain, K. Y.
    Fragneto, R. Y.
    Campbell, C. L.
    Booth, D. C.
    JOURNAL OF PERINATOLOGY, 2010, 30 (09) : 628 - 631
  • [8] Veletri® and Flolan® (Epoprostenol Sodium) in the Treatment of Pulmonary Arterial Hypertension
    Chin, K. M.
    Badesch, D. B.
    Robbins, I. M.
    Tapson, V. F.
    Palevsky, H.
    Kim, N. H.
    Kawut, S. M.
    Frost, A.
    Benton, W. W.
    Lemarie, J. C.
    Bodin, F.
    Rubin, L. J.
    McLaughlin, V. V.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2012, 31 (04): : S28 - S28
  • [9] Long-term safety of a new formulation of epoprostenol in pulmonary arterial hypertension
    Delcroix, Marion
    Simonneau, Gerald
    Bergot, Emmanuel
    Boonstra, Anco
    Granton, John
    Langleben, David
    Subias, Pilar Escribano
    Galie, Nazzareno
    Pfister, Thomas
    Lemarie, Jean-Christophe
    Sitbon, Olivier
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [10] Evaluation of a New Formulation of Epoprostenol Sodium in Japanese Patients with Pulmonary Arterial Hypertension (EPITOME4)
    Yuichi Tamura
    Tomohiko Ono
    Keiichi Fukuda
    Toru Satoh
    Shigetake Sasayama
    Advances in Therapy, 2013, 30 : 459 - 471
12345